Rare diseases
Investigational molecules
Locations
Route 206, Province Line Road, 08543, United States
Clinical research in schizophrenia focuses on persistent symptom control, with attention to positive and negative symptoms and the management of inadequately controlled disease.
The therapeutic emphasis includes ongoing evaluation of symptom burden in adults living with chronic psychotic illness.
Karuna Therapeutics Inc. runs clinical trials in conditions such as Dementia Alzheimer's type, Schizophrenia, Psychotic disorder, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis
BelgiumStudy on the Effectiveness and Safety of KarXT for Treating Psychosis in Patients with Alzheimer's Disease
BelgiumLong-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms
BulgariaStudy of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
